Gourt > Health > Pharmacy > Drugs and Medications > E > Efalizumab
Efalizumab (Raptiva®, Genentech) is a medication used to treat psoriasis. It is a recombinant humanized monoclonal antibody that binds to CD11a and acts as an immunosuppressant. It is administered once weekly by subcutaneous injection.
More on [ Efalizumab ]
Raptiva - Genentech - Official pharmaceutical site with information for patients and health professionals.
Meta Description: [ Psoriasis treatment begins with RAPTIVA (efalizumab), the only FDA-approved psoriasis treatment that is a one-dose, once-a-week treatment you can inject yourself. RAPTIVA for plaque psoriasis brought to you by Genentech. ]
Raptiva Consumer Information - US FDA information page, describing use, dosage, side effects, and related topics.
| Psoriasis Drug Raptiva Recalled Due To Brain Infection Risk | |
| Next Video | |
